» Articles » PMID: 12590640

Anthropometric, Haemodynamic, Humoral and Hormonal Evaluation in Patients with Incidental Adrenocortical Adenomas Before and After Surgery

Overview
Specialty Endocrinology
Date 2003 Feb 20
PMID 12590640
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To compare clinical and humoral parameters before and after surgery in patients with incidental adrenocortical adenomas.

Design: Six patients with subclinical Cushing's syndrome and nine with non-functioning adenomas were investigated before and 12 Months after removal of the mass.

Methods: Anthropometric (body weight, body mass index and waist to hip ratio), haemodynamic (blood pressure and heart rate), metabolic (lipids and oral glucose tolerance test (OGTT)), hormonal (cortisol, plasma renin activity, aldosterone, androgens and catecholamines) and bone metabolism (hydroxyproline, parathyroid hormone, osteocalcin and ostase) parameters were evaluated.

Results: In the whole group, a significant decrease in body weight (69.7+/-3.5 vs 70.8+/-3.5 kg, P<0.03), in systolic (135.3+/-5.1 vs 145.6+/-4.9 mmHg, P<0.009) and diastolic (83.7+/-1.9 vs 91.0+/-3.5 mmHg, P<0.03) blood pressure and in glucose levels in response to OGTT (106.4+/-9.6 vs 127.5+/-6.5 mg/dl, P<0.05) was observed after surgery. All other parameters examined did not change significantly. This trend was also found in both groups separately. Analytical data showed a high frequency of overweight/obesity (66.6%), hypertension (66.6%) and impaired glucose profile (26.6%) in our patients, with a greater prevalence of these cardiovascular risk factors in the subclinical Cushing's syndrome group. After surgery, values normalized or improved in eight out of ten hypertensive patients and in three out of four patients with impaired glucose profile.

Conclusions: Solid adrenocortical incidentalomas are associated with some cardiovascular risk factors which may be corrected after removal of the mass. Therefore, surgery may be an appropriate choice in patients with subclinical Cushing's syndrome but also in those with solid non-functioning adenomas and coexistent cardiovascular risk factors.

Citing Articles

Triglyceride-glucose index in patients with non-functioning adrenal incidentaloma, cortisol-secreting adrenal incidentaloma and healthy controls.

Meric C, Tasci I, Akin S, Candemir B, Guzel Esen S, Dag Z Am J Transl Res. 2024; 16(11):6679-6688.

PMID: 39678618 PMC: 11645597. DOI: 10.62347/JTQX7232.


Impact of adrenalectomy on hypertension in patients with nonfunctional adrenal tumors: a retrospective study.

Guo L, Yang L, Wang X, Bai X, Tuoheti K, Yisha Z World J Urol. 2024; 42(1):441.

PMID: 39046549 DOI: 10.1007/s00345-024-05134-7.


Management of Adrenal Cortical Adenomas: Assessment of Bone Status in Patients with (Non-Functioning) Adrenal Incidentalomas.

Trandafir A, Stanciu M, Albu S, Stoian V, Ciofu I, Persu C J Clin Med. 2023; 12(13).

PMID: 37445279 PMC: 10342680. DOI: 10.3390/jcm12134244.


Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.

Araujo-Castro M, Minguez Ojeda C, Sanchez Ramirez M, Gomez Dos Santos V, Pascual-Corrrales E, Fernandez-Argueso M Endocrine. 2022; 78(1):142-150.

PMID: 35751779 DOI: 10.1007/s12020-022-03120-w.


Preoperative prognostic nomogram for prophylactic steroid treatment of patients with subclinical Cushing's syndrome.

Lin D, Lin J, Hu X, Liu Y, Zhang J, Zhang L Transl Androl Urol. 2021; 10(1):426-437.

PMID: 33532330 PMC: 7844482. DOI: 10.21037/tau-20-1108.